A proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts

Proteomics

Volumn 8, Issue 15, 2008, Pages 3082-3093

  Kim, Seyoon ^a   Yong, Zu Lee ^a   Yu, Sam Kim ^a   Young, Yil Bahk ^a  

^a Yonsei University   (South Korea)

Author keywords

2 DE based proteomics; 3T3 mouse embryonic fibroblast; Expression system; NIH; Ras oncogene; Ras proteins

Indexed keywords

PROTEOME; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; EMBRYO; ENZYME REGULATION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSFORMATION; IMAGE ANALYSIS; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; ONCOGENE N RAS; ONCOGENE RAS; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DOXYCYCLINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; MICE; NIH 3T3 CELLS; PROTEINS; PROTEOMICS; RAS PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 49749125587     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800106     Document Type: Article

References (40)

1. Shields, J. M., Pruitt, K., McFall, A., Shaub, A. et al., Understanding Ras: 'It ain't over 'til if s over'. Trends Cell Biol. 2000, 10, 147-154.
2. Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M. et al., Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton - by Ras. Cell 1997, 89, 457-467.
3. Hancock, J. F., Ras proteins: Different signals from different locations. Nat. Rev. Mol. Cell Biol. 2003, 4, 373-384.
4. Marshall, C. J., Ras effectors. Curr. Opin. Cell Biol. 1996, 8, 197-204.
5. Carbone, A., Gusella, G. L., Radzioch, D., Varesio, L., Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogne 1991, 6, 731-737.
6. Maher, J., Baker, D. A., Manning, M., Dibb, N. J. et al., Evidence for cell-specific differences in transformation by N-, H-and K-ras. Oncogene 1995, 11, 1639-1647.
7. Walsh, A. B., Bar-Sagi, D., Differential activation of the Rac pathway by Ha-Ras and K-Ras. J. Biol. Chem. 2001, 276, 15609-15201.
8. Voice, J. K., Klemke, R. L., Le, A., Jackson, J. H., Four Human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 1999, 274, 17164-17170.
9. Yan, J., Roy, S., Apolloni, A., Lane, A. et al., Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J. Biol. Chem. 1998, 273, 24052-24056.
10. Blacktock, W. P., Weir, M. P., Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999, 17, 121-127.
11. Park, J. W., Kim, S., Lim, K. J., Simpson, R. J. et al., A proteomic approach for unraveling the oncogenic H-Ras protein networks in NIH/3T3 mouse embryonic fibroblast cells. Proteomics 2006, 6, 1175-1186.
12. Young, T. W., Mei, F. C., Yang, G., Thompson-Lanza, J. A. et al., Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry. Cancer Res. 2004, 64, 4577-4584.
13. Jin, B. F., He, K., Wang, H. X., Bai, B. et al., Proteomics analysis reveals insight into the mechanism of H-Ras-mediated transformation. J. Proteome Res. 2006, 5, 2815-2823.
14. Ji, H., Moritz, R. L., Kim, Y. S., Zhu, H.-J. et al., Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics. Eelctrophoresis 2007, 28, 1997-2008.
15. Lim, Y., Han, I., Jeon, J., Park, H. et al., Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. J. Biol. Chem. 2004, 279, 29060-29065.
16. Kim, S.-y., Kim, Y. S., Bahk, Y. Y., Proteome changes induced by expression of tumor suppressor PTEN. Mol. Cells 2003, 15, 396-405.
17. Shim, J. H., Danielpour, D., Lee, C., Kim, Y. S. et al., Proteome profile changes during transdifferentiation of NRP-152 rat prostatic basal epithelial cells. Mol. Cells 2004, 17, 108-116.
18. Shim, J. H., Kim, Y. S., Bahk, Y. Y., Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells. Proteomics 2006, 6, 81-93.
19. Yan, J. X., Wait, R., Berkelman, T., Harry, R. A. et al., A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21, 3666-3672.
20. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
21. Krontiris, T. G., Cooper, G. M., Transforming activity of human tumor DNAs. Proc. Natl. Acad. Sci. USA 1981, 78, 1181-1184.
22. Perucho, M., Goldfarb, M., Shimizu, K., Lama, C. et al., Human-tumor-derived cell lines contain common and different transforming genes. Cell 1981, 27, 467-476.
23. Shih, C., Weinberg, R. A., Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 1982, 29, 161-169.
24. Barral, J. M., Broadley, S. A., Schaffar, G., Hartl, F. U., Roles of molecular chaperones in protein misfolding diseases. Semin. Cell Dev. Biol. 2004, 15, 17-29.
25. Willison, K. R., Horwich, A. L., in: Ellis, R. J. (Ed.), The Chaperonins, Academic Press, San Diego 1996, pp. 107-136.
26. Dingwall, C., Laskey, R. A., Nucleoplasmin: The archetypal molecular chaperone. Semin. Cell Biol. 1990, 1, 11-17.
27. Shackleford, G. M., Ganguly, A., MacArthur, C. A., Cloning, expression and nuclear localization of human NPM3, a member of the nucleophosmin/ nucleoplasmin family of nuclear chaperones. BMC Genomics 2001, 2, 8-13.
28. Recktenwald, C. V., Mendler, S., Lichtenfels, R., Kellner, R. et al., Influence of Ki-ras-driven oncogenic transformation on the protein network of murine fibroblasts. Proteomics 2007, 7, 385-398.
29. Young, T. W., Mei, F. C., Rosen, D. G., Yang, G. et al., Up-regulation of tumor susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses. Mol. Cell. Proteomics 2007, 6, 294-304.
30. Cheng, X., Young, T. W., Mei, F. C., Proteomics analyses of ovarian cancer using genetically defined human ovarian cancer models. Front. Biosci 2007, 12, 5166-5174.
31. Shields, J. M., Mehta, H., Pruitt, K., Der, C. J., Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol. Cell. Biol. 2002, 22, 2304-2317.
32. Bharadwaj, S., Prasad, G. L., Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. Cancer Lett. 2002, 183, 205-213.
33. De Carte, V., Impe, K. V., Bruyneel, E., Boucherie, C. et al., Increased importin-beta-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J. Cell Sci. 2004, 117, 5283-5292.
34. Witke, W., Li, W., Kwiatkowski, D. J., Southwick, F. S., Comparisons of CapG and gelsolin-null macrophages: Demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J. Cell Biol. 2001, 154, 775-784.
35. Ayllón, V., Martinez, A. C., Garcia, A., Cayla, X. et al., Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J. 2000, 19, 2237-2246.
36. Nagakubo, D., Taira, T., Kitaura, H., Ikeda, M. et al., DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 1997, 231, 509-513.
37. Hess, A., Wijayanti, N., Neuschäfer-Rube, A. P., Katz, N. et al., Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 2003, 278, 45419-45434.
38. Morrison, H., Sperka, T., Manent, J., Giovannini, M. et al., Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res. 2007, 67, 520-517.
39. Rajalingam, K., Rudel, T., Ras-Raf signaling needs prohibitin. Cell Cycle 2005, 4, 1503-1505.
40. Alfonso, P., Dolado, I., Swat, A., Núñez, A. et al., Proteomic analysis of p38α mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblast. Proteomics 2006, 6, S262-S271.